When the U.S. began distributing COVID-19 vaccines this winter, Jordan Tralins ’23 found it odd that her social media feeds didn’t have any factual information about the shots. Tralins decided to do something about it.
From monitoring blood pressure to potholes: Professor Max Zhang's Internet of Things (IoT) course teaches students how to leverage IoT sensor technology to solve real-world problems and help the community.
A Cornell collaboration crossing medicine, law, technology and communication is aiming to encourage the use of health care benefits by refugees in the U.S. – who often suffer poor health but are using these entitlements less than they have in the past.
This is the largest federal grant ever awarded to Weill Cornell Medicine and the fourth consecutive time this initiative has been funded by the NIH, representing 20 years of continuous funding.
Following a sweeping effort in 2019 to address clinical care team well-being across Weill Cornell Medicine, physicians note a reduction in stress and feelings of burnout compared to previous surveys, according to a new report from the institution.
A newly discovered small molecule could be sprayed into people’s noses to prevent COVID-19 illness prior to exposure and provide early treatment if administered soon after infection, according to a study in mice led by Cornell researchers.
An alternative statistical method honed and advanced by Cornell researchers can make clinical trials more reliable and trustworthy while also helping to remedy what has been called a “replicability crisis” in the scientific community.
Cornell Atkinson is soliciting nominations for The Earthshot Prize, a new global award supported by The Duke and Duchess of Cambridge to tackle the world’s biggest environmental challenges.
Researchers at the College of Veterinary Medicine plan to develop an enzyme-based technology into a range of diagnostic tests that can be performed anywhere using a handheld device.
Researchers at Weill Cornell Medicine have identified significant differences in the molecular characteristics of tumors from younger and older cancer patients across several cancer types.